Cargando…
CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397560/ https://www.ncbi.nlm.nih.gov/pubmed/28425210 http://dx.doi.org/10.1002/psp4.12186 |
| _version_ | 1783230283951112192 |
|---|---|
| author | Garrido, MJ Berraondo, P Trocóniz, IF |
| author_facet | Garrido, MJ Berraondo, P Trocóniz, IF |
| author_sort | Garrido, MJ |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5397560 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53975602017-04-21 CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy Garrido, MJ Berraondo, P Trocóniz, IF CPT Pharmacometrics Syst Pharmacol Corrigendum John Wiley and Sons Inc. 2017-04-06 2017-04 /pmc/articles/PMC5397560/ /pubmed/28425210 http://dx.doi.org/10.1002/psp4.12186 Text en © 2017 ASCPT |
| spellingShingle | Corrigendum Garrido, MJ Berraondo, P Trocóniz, IF CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy |
| title | CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy |
| title_full | CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy |
| title_fullStr | CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy |
| title_full_unstemmed | CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy |
| title_short | CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy |
| title_sort | corrigendum: commentary on pharmacometrics for immunotherapy |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397560/ https://www.ncbi.nlm.nih.gov/pubmed/28425210 http://dx.doi.org/10.1002/psp4.12186 |
| work_keys_str_mv | AT garridomj corrigendumcommentaryonpharmacometricsforimmunotherapy AT berraondop corrigendumcommentaryonpharmacometricsforimmunotherapy AT troconizif corrigendumcommentaryonpharmacometricsforimmunotherapy |